Proton Partners International receives
formal planning permission
PROTON Partners International has successfully received
formal planning permission to build its third oncology centre in England. The
₤35 million cancer treatment centre will be built in the new ₤1 billion
Paddington Village, part of Knowledge Quarter Liverpool (KQ Liverpool). This
will be one of four centres currently being developed by Proton Partners
International, making the company the world's largest developer of proton beam
The oncology centre, which will be known as The Rutherford Cancer Centre North
West, will provide an all-encompassing cancer service for patients, offering
proton beam therapy, as well as chemotherapy, traditional radiotherapy and
imaging. It is expected that conventional treatments will be available in 2018
and proton beam therapy in 2019.
Joe Anderson, Mayor of Liverpool, said:- "This planning permission is
great news for Proton Partners, Paddington Village and KQ Liverpool and we look
forward to seeing the building take shape.
KQ Liverpool is gaining real momentum now and, as a world-leader in medical and
life sciences research, is fast becoming a major catalyst in the City's
Mike Moran, chief executive officer of Proton Partners
International, said:- "This marks the next step in our mission to make the
best cancer technology accessible to patients across the UK and I'm proud that
our next centre will be in my home Town of Liverpool.
Knowledge Quarter Liverpool is a really exciting project to be involved with.
It's already proving to be a world class destination for business, science and
innovation, which sits right at the core of our values as a company. By building
centres across the country we hope to transform the level of cancer treatment
available to patients and therefore receiving planning permission is a key
milestone for us. Not only will our centre bring an innovative industry to
Liverpool, but it will also bring skilled job opportunities that will play a key
role in boosting the local economy."
There are currently no operational high energy proton beam therapy facilities in
the UK and the demand for more specialised cancer care is growing.
Proton Partners International is building 3 other UK cancer centres, in Newport,
Northumberland and Reading, and further sites are under consideration. The
Newport centre recently opened to receive patient referrals for chemotherapy and
radiotherapy, and the proton beam therapy system is currently undergoing
It is expected The Rutherford Cancer Centres will each be able to treat up to
500 patients a year and treatment will be available to medically insured private
patients, self paying patients and patients referred by the NHS.
Proton Partners International is also building a genomics research centre at the
Life Sciences Accelerator building in Liverpool which will be the first part of
a health campus set to surround the ₤335m new Royal Liverpool Hospital. The
genomics programme will support Proton Partners International's broader research
work with the University of Liverpool's Physics Department.